학술논문

Collecting and Analyzing Clinical Information and its Issues / 臨床情報の収集・分析と課題
Document Type
Journal Article
Source
医療と社会 / Iryo To Shakai. 2022, 32(1):51
Subject
COVID-19
Clinical trial
Registry
レジストリ
臨床研究
Language
Japanese
ISSN
0916-9202
1883-4477
Abstract
During an outbreak of an infectious disease, it is necessary to collect clinical information from the perspective of epidemiological and clinical response. the first few hundred(FF100)study in the UK during the 2009 H1N1 outbreak and the report of 99 cases from Wuhan during the COVID-19 outbreak were cited in many papers around the world. In the early stages of the COVID-19 epidemic, Japan failed to collect and share such clinical information promptly, and there were delays in providing specimens from patients to research institutions and companies. This was a major stumbling block in terms of public health measures, clinical response, and research and development in response to COVID-19 in Japan. In the future, it will be necessary to strengthen the research capacity of medical institutions designated for infectious diseases, improve the research environment, actively conduct epidemiological surveys of information in hospital information systems, especially electronic medical records, and build a strategic knowledge sharing system. In addition to governmental inspections, it is necessary to enhance the detection and genome analysis systems of microorganisms in medical institutions, research institutes, and the private sector.